The European Cystic Fibrosis Society Board has agreed to establish a new Special Interest Group – the European Cystic Fibrosis Pharmacy Group. The Group is committed to promoting good practice in the supply of, and equitable access to, medicines and information about medicines to patients; setting high standards of pharmacy practice; supporting patients to achieve greatest benefit from their medicines; promoting the role of pharmacists and affiliated professions in the pharmaceutical care of patients with CF; delivering continuing professional education and development, and pharmacy practice research. This new group welcomes membership from pharmacists, pharmacologists and associated professionals with an interest in the care of people with CF. For more information visit ECFS website.
420
previous post